The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The closing price of NovoCure Ltd (NASDAQ: NVCR) was $12.43 for the day, up 4.37% from the previous closing price of $11.91. In other words, the price has increased by $4.37 from its previous closing price. On the day, 1.44 million shares were traded. NVCR stock price reached its highest trading level at $12.47 during the session, while it also had its lowest trading level at $11.96.
Ratios:
Our analysis of NVCR’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.39 and its Current Ratio is at 1.45. In the meantime, Its Debt-to-Equity ratio is 2.00 whereas as Long-Term Debt/Eq ratio is at 0.40.
On July 08, 2025, Ladenburg Thalmann started tracking the stock assigning a Buy rating and target price of $30.
Evercore ISI Upgraded its In-line to Outperform on December 02, 2024, whereas the target price for the stock was revised from $18 to $30.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 29 ’25 when Brackmann Christoph bought 20,000 shares for $11.59 per share. The transaction valued at 231,800 led to the insider holds 141,150 shares of the business.
Stafford Kristin sold 999 shares of NVCR for $17,259 on Jun 03 ’25. The Director now owns 3,054 shares after completing the transaction at $17.28 per share. On Jun 03 ’25, another insider, LEUNG GABRIEL, who serves as the Director of the company, sold 999 shares for $17.31 each. As a result, the insider received 17,297 and left with 81,229 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NVCR now has a Market Capitalization of 1389661568 and an Enterprise Value of 1178392192. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.21 while its Price-to-Book (P/B) ratio in mrq is 3.98. Its current Enterprise Value per Revenue stands at 1.87 whereas that against EBITDA is -7.418.
Stock Price History:
The Beta on a monthly basis for NVCR is 0.58, which has changed by -0.3151515 over the last 52 weeks, in comparison to a change of 0.1513431 over the same period for the S&P500. Over the past 52 weeks, NVCR has reached a high of $34.13, while it has fallen to a 52-week low of $10.87. The 50-Day Moving Average of the stock is -15.85%, while the 200-Day Moving Average is calculated to be -36.97%.
Shares Statistics:
NVCR traded an average of 1.68M shares per day over the past three months and 1398010 shares per day over the past ten days. A total of 111.80M shares are outstanding, with a floating share count of 98.86M. Insiders hold about 11.57% of the company’s shares, while institutions hold 84.19% stake in the company. Shares short for NVCR as of 1753920000 were 5224090 with a Short Ratio of 3.11, compared to 1751241600 on 5228810. Therefore, it implies a Short% of Shares Outstanding of 5224090 and a Short% of Float of 7.380000000000001.
